Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 19 May 2022 for ENDRA Life Sciences Inc., €919.
Filing timeline
BuySaleFrancois Roger Michelon
Insider track record
Disclosed buys
1
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+22.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Francois Roger Michelon: trading record in brief
This profile gathers the share dealings of Francois Roger Michelon in ENDRA Life Sciences Inc., where the filings describe the role as chief executive. Over a trading history stretching from 12 May 2017 to 17 May 2022, the count stands at 7 filings.
On the open market, the record shows 1 purchase worth €919 and 1 sale worth €49k. The net balance comes to €48k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants. 2022 to date brings 1 purchase and no sales.
The latest filing, published on 19 May 2022, reports an open-market purchase of €919 in ENDRA Life Sciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Francois Roger Michelon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
5,100 shares@ US$0.19100.0% of flowCommon StockSEC:0001209191-22-030307:0
Canonical exit: 15 Aug 2022 (T+90)
1 of 1 declaration
